loading...| Preferred Name |
Acute myeloid leukemia |
| ID |
http://www.orpha.net/ORDO/Orphanet_519 |
| alternative_term |
Acute myelogenous leukemia AML |
| definition |
A group of neoplasms arising from precursor cells committed to the myeloid cell-line differentiation. All of them are characterized by clonal expansion of myeloid blasts. They manifest by fever, pallor, anemia, hemorrhages and recurrent infections. |
| definition_citation |
Orphanet |
| expertlink |
https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=519 |
| has_age_of_onset |
All ages |
| hasDbXref |
MeSH:D015470 MedDRA:10000880 OMIM:601626 ICD-10:C92.0 UMLS:C1879321 ICD-11:2A60 |
| label |
Acute myeloid leukemia |
| notation |
Clinical group ORPHA:519 |
| prefixIRI |
ORDO:Orphanet_519 |
| prefLabel |
Acute myeloid leukemia |
| present_in |
Worldwide AND has_annual_incidence_average_value : 2.5 AND has_annual_incidence_range : 1-9 / 100 000 United States AND has_annual_incidence_average_value : 3.7 AND has_annual_incidence_range : 1-9 / 100 000 Europe AND has_lifetime_prevalence_average_value : 10.98 AND has_lifetime_prevalence_range : 1-5 / 10 000 France AND has_annual_incidence_average_value : 4.4 AND has_annual_incidence_range : 1-9 / 100 000 Europe AND has_annual_incidence_average_value : 3.39 AND has_annual_incidence_range : 1-9 / 100 000 Europe AND has_point_prevalence_average_value : 10.0 AND has_point_prevalence_range : 1-5 / 10 000 Denmark AND has_annual_incidence_average_value : 2.8 AND has_annual_incidence_range : 1-9 / 100 000 |
| subClassOf |